Aurora kinase inhibition as a potential new therapeutic strategy in childhood adrenocortical tumor (2011)
- Authors:
- USP affiliated authors: SCRIDELI, CARLOS ALBERTO - FMRP ; QUEIROZ, ROSANE GOMES DE PAULA - FMRP ; TONE, LUIZ GONZAGA - FMRP
- Unidade: FMRP
- Subjects: NEOPLASIAS DO CÓRTEX SUPRARRENAL; PROTEÍNAS QUINASES; GENÉTICA; CRIANÇAS
- Language: Inglês
- Imprenta:
- Source:
- Título do periódico: Pediatric Blood & Cancer
- ISSN: 1545-5009
- Volume/Número/Paginação/Ano: v. 57, n. 5, p. 801, res. PL014, 2011
- Conference titles: Annual Conference of the International Society of Paediatric Oncology (SIOP)
-
ABNT
BORGES, Kleiton Silva et al. Aurora kinase inhibition as a potential new therapeutic strategy in childhood adrenocortical tumor. Pediatric Blood & Cancer. Hoboken: Faculdade de Medicina de Ribeirão Preto, Universidade de São Paulo. . Acesso em: 25 abr. 2024. , 2011 -
APA
Borges, K. S., Castro-Gamero, A. M., Queiroz, R. G. de P., Tone, L. G., & Scrideli, C. A. (2011). Aurora kinase inhibition as a potential new therapeutic strategy in childhood adrenocortical tumor. Pediatric Blood & Cancer. Hoboken: Faculdade de Medicina de Ribeirão Preto, Universidade de São Paulo. -
NLM
Borges KS, Castro-Gamero AM, Queiroz RG de P, Tone LG, Scrideli CA. Aurora kinase inhibition as a potential new therapeutic strategy in childhood adrenocortical tumor. Pediatric Blood & Cancer. 2011 ; 57( 5): 801.[citado 2024 abr. 25 ] -
Vancouver
Borges KS, Castro-Gamero AM, Queiroz RG de P, Tone LG, Scrideli CA. Aurora kinase inhibition as a potential new therapeutic strategy in childhood adrenocortical tumor. Pediatric Blood & Cancer. 2011 ; 57( 5): 801.[citado 2024 abr. 25 ] - Study adrenocortical tumors in children and adolescent by technique comparative genomic hybridization (CGH)
- Role of SHOC2 gene in the chemotherapy sensibility process in childhood acute lymphoblastic leukemia
- Can zebularine be an altenative drug to tomozolomide resistant glioblastoma ?
- Perfil de expressão dos genes relacionados à migração e adesão celular (TIMP-1, TIMP-2, MMP-2 and MMP-9) em crianças com crianças com leucemia linfóide aguda (LLA): correlação com variáveis clínica e biológica
- Fc'gama' receptor gene polymorphisms in childhood immune thrombocytopenic purpura
- Role of the CYP2D6, EPHX1, MPO, and NQO1 genes in the susceptibiblity to acute lymphoblastic leukemia in Brazilian children
- mRNA expression of NMP2 and MMP9 and TIMP1 and TIMP2 in childhood all: potential role of TIMP1 as an adverse prognostic factor
- Protein expression of matrix metalloproteinase (MMP-1, -2, -3, -9 and -14) in Ewing family tumors and medulloblastomas of pediatric patients
- Low mRNA expression of the apoptosis-related genes CASP3, CASP8, and FAS is associated with low induction treatment response in childhood acute lymphoblastic leukemia (ALL)
- Análise de micrornas como potenciais marcadores de prognóstico na leucemia linfoide aguda da criança e do adolescente
How to cite
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
